Form 8-K ImmunityBio, Inc. For: Dec 23
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Take-Two stock drops as GTA 6 leaks continue
- GameStop posts higher income despite revenue drop in Q2 2026
- At least eight die, 18 missing after ferry capsizes off North Cyprus
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- Goldman Sachs raises humanoid robot forecast, sees auto role
ImmunityBio amends stock sale agreement to authorize $460M offering
December 29, 2025 6:04 AM ESTImmunityBio Inc. (NASDAQ: IBRX) amended its at-the-market stock offering agreement with Jefferies LLC on December 23, authorizing the sale of an additional $459.97 million in common stock shares.
The biotechnology company modified its existing Open Market Sale Agreement from April 2021, which allows for periodic... More
